Loteprednol/Tobramycin Ophthalmic Dosage
This dosage information may not include all the information needed to use Loteprednol/Tobramycin Ophthalmic safely and effectively. See additional information for Loteprednol/Tobramycin Ophthalmic.
The information at Drugs.com is not a substitute for medical advice. ALWAYS consult your doctor or pharmacist.
Usual Adult Dose for:
Additional dosage information:
Usual Adult Dose for Uveitis
1 to 2 drops instilled in conjunctival sac of affected eye(s) every 4 to 6 hours
During the initial 24 to 48 hours of treatment the frequency may be increased to every 1 to 2 hours.
As clinical signs improve the frequency may be decreased gradually.
Usual Adult Dose for Iritis
1 to 2 drops instilled in conjunctival sac of affected eye(s) every 4 to 6 hours
During the initial 24 to 48 hours of treatment the frequency may be increased to every 1 to 2 hours.
As clinical signs improve the frequency may be decreased gradually.
Usual Adult Dose for Bacterial Conjunctivitis
1 to 2 drops instilled in conjunctival sac of affected eye(s) every 4 to 6 hours
During the initial 24 to 48 hours of treatment the frequency may be increased to every 1 to 2 hours.
As clinical signs improve the frequency may be decreased gradually.
Usual Adult Dose for Keratitis
1 to 2 drops instilled in conjunctival sac of affected eye(s) every 4 to 6 hours
During the initial 24 to 48 hours of treatment the frequency may be increased to every 1 to 2 hours.
As clinical signs improve the frequency may be decreased gradually.
Usual Adult Dose for Cyclitis
1 to 2 drops instilled in conjunctival sac of affected eye(s) every 4 to 6 hours
During the initial 24 to 48 hours of treatment the frequency may be increased to every 1 to 2 hours.
As clinical signs improve the frequency may be decreased gradually.
Renal Dose Adjustments
Data not available
Liver Dose Adjustments
Data not available
Precautions
Intraocular pressure should be monitored if used for more than 10 days. Patients should be examined (e.g., slit lamp biomicroscopy and/or fluorescein stain) if used for more than 14 days.
Patients should be reevaluated if signs and symptoms do not improve within 2 days.
Per manufacturer recommendation contacts should not be worn during loteprednol-tobramycin therapy.
Safety and effectiveness have not been established in pediatric patients (less than 18 years of age).
Dialysis
Data not available
Other Comments
The bottle should be shaken vigorously prior to use.
